Skip to main content
INTI logo

INTI · Inhibitor Therapeutics, Inc. · Shareholders & Ownership

Track INTI — free
$0.11 At close · Oct 16
Market Cap
$19.12M
Shares
173.79M
Volume · Oct 16 3900 Avg daily vol (3M) 15.6K

Every disclosed holder of INTI in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns INTI

Holder group Shares % Out
Institutional (13F) 0 0.00%
Insiders (Forms 3, 4, 5) 48,443,402 27.87%
13D/G-only blocks 0 0.00%
Remaining 125,348,566 72.13%
Registered funds (N-PORT, not summed) 0 0.00%

Shares outstanding: 173,791,968, the issuer's latest cover-page count restated onto today's split basis.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of INTI

# Holder Shares
1
OSMAN RONALD E
Insider CIK 1380466 · May 4, 2026
Director, 10% Owner, issuer-wide
23,614,985
2
Black Robe Capital LLC
Insider CIK 1977553 · Jul 1, 2026
10% Owner, issuer-wide
19,901,057
3
MCNULTY JAMES A
Insider CIK 1275857 · Dec 2, 2024
Director, issuer-wide
1,946,135
4
SEARS SAMUEL P JR
Insider CIK 1238483 · May 4, 2026
Director, issuer-wide
1,229,543
5
Yanez Michelle
Insider CIK 1958023 · May 4, 2026
Chief Financial Officer, issuer-wide
1,221,271
6
Vasisht Niraj
Insider CIK 1662930 · May 5, 2026
Director, issuer-wide
200,000
7
Jerman Michael Allen
Insider CIK 1979732 · May 4, 2026
Director, issuer-wide
180,411
8
ODONNELL FRANCIS E JR
Insider CIK 1066040 · May 4, 2026
Director, See Remarks, 10% Owner, issuer-wide
150,000

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.

Key facts CIK 1042418 CUSIP 45720M105 Visit website Investor relations